{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:11:12Z","timestamp":1791803472305,"version":"4.3.4"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00105-021-04864-8","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T09:03:36Z","timestamp":1625562216000},"page":"692-699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hidradenitis suppurativa\/Acne inversa\u00a0\u2013 operative Optionen, Rekonstruktionen und Kombinationen mit medikament\u00f6sen Therapien\u00a0\u2013 Ein Update","Hidradenitis suppurativa \/acne inversa\u2014surgical options, reconstruction and combinations with drug therapies\u2014an update"],"prefix":"10.1007","volume":"72","author":[{"given":"P.","family":"Cramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schneider-Burrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Podda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. G.","family":"Bechara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"4864_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00105-015-3616-y","volume":"66","author":"J Kirschke","year":"2015","unstructured":"Kirschke\u00a0J, Hessam\u00a0S, Bechara\u00a0FG (2015) Hidradenitis suppurativa\/acne inversa: Ein Update. Hautarzt 66:413\u2013422. https:\/\/doi.org\/10.1007\/s00105-015-3616-y","journal-title":"Hautarzt"},{"key":"4864_CR2","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s00105-017-4079-0","volume":"68","author":"R Sabat","year":"2017","unstructured":"Sabat\u00a0R (2017) Acne inversa\/hidradenitis suppurativa: a\u00a0challenge for the future. Hautarzt 68:994\u2013998. https:\/\/doi.org\/10.1007\/s00105-017-4079-0","journal-title":"Hautarzt"},{"key":"4864_CR3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00105-017-4082-5","volume":"68","author":"R Sabat","year":"2017","unstructured":"Sabat\u00a0R, Tsaousi\u00a0A, Rossbacher\u00a0J et\u00a0al (2017) Acne inversa\/hidradenitis suppurativa: an update. Hautarzt 68:999\u20131006. https:\/\/doi.org\/10.1007\/s00105-017-4082-5","journal-title":"Hautarzt"},{"issue":"12","key":"4864_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11916-017-0647-3","volume":"21","author":"ZS Patel","year":"2017","unstructured":"Patel\u00a0ZS, Hoffman\u00a0LK, Buse\u00a0DC, Grinberg\u00a0AS, Afifi\u00a0L, Cohen\u00a0SR et\u00a0al (2017) Pain, psychological comorbidities, disability, and impaired quality of life in hidradenitis suppurativa. Curr Pain Headache Rep 21(12):49","journal-title":"Curr Pain Headache Rep"},{"issue":"3","key":"4864_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/1203475418823529","volume":"23","author":"ML McPhie","year":"2019","unstructured":"McPhie\u00a0ML, Bridgman\u00a0AC, Kirchhof\u00a0MG (2019) Combination therapies for hidradenitis suppurativa: a\u00a0retrospective chart review of 31\u00a0patients. J\u00a0Cutan Med Surg 23(3):270\u2013276","journal-title":"J Cutan Med Surg"},{"key":"4864_CR6","first-page":"729","volume-title":"Dermatologic surgery. Principles and practice","author":"H Hurley","year":"1989","unstructured":"Hurley\u00a0H (1989) Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus. Surgical approach. In: Roenigk\u00a0RK, Roenigk\u00a0HH Jr (Hrsg) Dermatologic surgery. Principles and practice. Dekker, New York, S\u00a0729\u2013739"},{"issue":"Suppl","key":"4864_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/exd.12954","volume":"25","author":"FG Bechara","year":"2016","unstructured":"Bechara\u00a0FG (2016) MIBHS: a\u00a0concept to distinguish between medical and surgical treatment in hidradenitis suppurativa. Exp Dermatol 25(Suppl):8. https:\/\/doi.org\/10.1111\/exd.12954","journal-title":"Exp Dermatol"},{"key":"4864_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s15006-016-8662-6","volume":"158","author":"FG Bechara","year":"2016","unstructured":"Bechara\u00a0FG, Hessam\u00a0S (2016) Hidradenitis suppurativa. MMW Fortschr Med 158:52\u201353. https:\/\/doi.org\/10.1007\/s15006-016-8662-6","journal-title":"MMW Fortschr Med"},{"issue":"1","key":"4864_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","volume":"81","author":"A Alikhan","year":"2019","unstructured":"Alikhan\u00a0A, Sayed\u00a0C, Alavi\u00a0A, Alhusayen\u00a0R, Brassard\u00a0A, Burkhart\u00a0C et\u00a0al (2019) North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J\u00a0Am Acad Dermatol 81(1):76\u201390","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 5","key":"4864_CR10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1610-0387.2012.08006.x","volume":"10","author":"CC Zouboulis","year":"2012","unstructured":"Zouboulis\u00a0CC, Bechara\u00a0FG, Fritz\u00a0K et al (2012) S1-Leitlinie zur Therapie der Hidradenitis suppurativa\/Acne inversa. J\u00a0Dtsch Dermatol Ges 10(Suppl 5):S1\u2013S31. https:\/\/doi.org\/10.1111\/j.1610-0387.2012.08006.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"4864_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"29","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis\u00a0CC, Desai\u00a0N, Emtestam\u00a0L et\u00a0al (2015) European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J\u00a0Eur Acad Dermatol Venereol 29:619\u2013644. https:\/\/doi.org\/10.1111\/jdv.12966","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4864_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/bjs.1800790905","volume":"79","author":"AK Banerjee","year":"1992","unstructured":"Banerjee\u00a0AK (1992) Surgical treatment of hidradenitis suppurativa. Br J Surg 79:863\u2013866","journal-title":"Br J Surg"},{"key":"4864_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMcp1014163","volume":"366","author":"GBE Jemec","year":"2012","unstructured":"Jemec\u00a0GBE (2012) Clinical practice. Hidradenitis suppurativa. N\u00a0Engl J Med 366:158\u2013164. https:\/\/doi.org\/10.1056\/NEJMcp1014163","journal-title":"N Engl J Med"},{"issue":"1","key":"4864_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jdv.15233","volume":"33","author":"CC Zouboulis","year":"2019","unstructured":"Zouboulis\u00a0CC, Bechara\u00a0FG, Dickinson-Blok\u00a0JL, Gulliver\u00a0W, Horv\u00e1th\u00a0B, Hughes\u00a0R et al (2019) Hidradenitis suppurativa\/acne inversa: a\u00a0practical framework for treatment optimization\u2014Systematic review and recommendations from the HS ALLIANCE working group. J\u00a0Eur Acad Dermatol Venereol 33(1):19\u201331","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4864_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jaad.2009.12.018","volume":"63","author":"HH van der Zee","year":"2010","unstructured":"van der Zee\u00a0HH, Prens\u00a0EP, Boer\u00a0J (2010) Deroofing: a\u00a0tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J\u00a0Am Acad Dermatol 63:475\u2013480. https:\/\/doi.org\/10.1016\/j.jaad.2009.12.018","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"4864_CR16","first-page":"698","volume":"17","author":"RA Dahmen","year":"2019","unstructured":"Dahmen\u00a0RA, Gkalpakiotis\u00a0S, Mardesicova\u00a0L, Arenberger\u00a0P, Arenbergerova\u00a0M (2019) Deroofing followed by thorough sinus tract excision: a\u00a0modified surgical approach for hidradenitis suppurativa. J\u00a0Dtsch Dermatol Ges 17(7):698\u2013702","journal-title":"J Dtsch Dermatol Ges"},{"key":"4864_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1524-4725.2007.34042.x","volume":"34","author":"AB Aksakal","year":"2008","unstructured":"Aksakal\u00a0AB, Adi\u015fen\u00a0E (2008) Hidradenitis suppurativa: importance of early treatment; efficient treatment with electrosurgery. Dermatol Surg 34:228\u2013231. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.34042.x","journal-title":"Dermatol Surg"},{"key":"4864_CR18","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1524-4725.2011.02255.x","volume":"38","author":"S van Hattem","year":"2012","unstructured":"van Hattem\u00a0S, Spoo\u00a0JR, Horv\u00e1th\u00a0B et\u00a0al (2012) Surgical treatment of sinuses by deroofing in hidradenitis suppurativa. Dermatol Surg 38:494\u2013497. https:\/\/doi.org\/10.1111\/j.1524-4725.2011.02255.x","journal-title":"Dermatol Surg"},{"key":"4864_CR19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1524-4725.2009.01427.x","volume":"36","author":"PG Hazen","year":"2010","unstructured":"Hazen\u00a0PG, Hazen\u00a0BP (2010) Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization. Dermatol Surg 36:208\u2013213. https:\/\/doi.org\/10.1111\/j.1524-4725.2009.01427.x","journal-title":"Dermatol Surg"},{"key":"4864_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2340\/00015555-2258","volume":"96","author":"IC Janse","year":"2016","unstructured":"Janse\u00a0IC, Hellinga\u00a0J, Blok\u00a0JL et al (2016) Skin-tissue-sparing excision with electrosurgical peeling: a\u00a0case series in hidradenitis suppurativa. Acta Derm Venereol 96:390\u2013391. https:\/\/doi.org\/10.2340\/00015555-2258","journal-title":"Acta Derm Venereol"},{"key":"4864_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/jdv.12376","volume":"29","author":"JL Blok","year":"2015","unstructured":"Blok\u00a0JL, Spoo\u00a0JR, Leeman\u00a0FWJ et al (2015) Skin-Tissue-sparing Excision with Electrosurgical Peeling (STEEP): a\u00a0surgical treatment option for severe hidradenitis suppurativa Hurley stage II\/III. J\u00a0Eur Acad Dermatol Venereol 29:379\u2013382. https:\/\/doi.org\/10.1111\/jdv.12376","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4864_CR22","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1046\/j.1365-2133.1998.02524.x","volume":"139","author":"Y Endo","year":"1998","unstructured":"Endo\u00a0Y, Tamura\u00a0A, Ishikawa\u00a0O, Miyachi\u00a0Y (1998) Perianal hidradenitis suppurativa: early surgical treatment gives good results in chronic or recurrent cases. Br J Dermatol 139:906\u2013910","journal-title":"Br J Dermatol"},{"key":"4864_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00006534-195102000-00007","volume":"7","author":"PW Greeley","year":"1951","unstructured":"Greeley\u00a0PW (1951) Plastic surgical treatment of chronic suppurative hidradenitis. Plast Reconstr Surg 7:143\u2013146","journal-title":"Plast Reconstr Surg"},{"key":"4864_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1479-666X(05)80006-X","volume":"3","author":"A Mandal","year":"2005","unstructured":"Mandal\u00a0A, Watson\u00a0J (2005) Experience with different treatment modules in hidradenitis suppuritiva: a\u00a0study of 106\u00a0cases. Surgeon 3:23\u201326","journal-title":"Surgeon"},{"issue":"5","key":"4864_CR25","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/bjd.17537","volume":"180","author":"JR Ingram","year":"2019","unstructured":"Ingram\u00a0JR, Collier\u00a0F, Brown\u00a0D, Burton\u00a0T, Burton\u00a0J, Chin\u00a0MF et\u00a0al (2019) British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018. Br J Dermatol 180(5):1009\u20131017","journal-title":"Br J Dermatol"},{"key":"4864_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2298\/ACI1202091B","volume":"59","author":"S Bilali","year":"2012","unstructured":"Bilali\u00a0S, Todi\u00a0V, Lila\u00a0A et\u00a0al (2012) Surgical treatment of chronic hidradenitis suppurativa in the gluteal and perianal regions. Acta Chir Iugosl 59:91\u201395","journal-title":"Acta Chir Iugosl"},{"key":"4864_CR27","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/0002-9610(82)90547-5","volume":"144","author":"JR Broadwater","year":"1982","unstructured":"Broadwater\u00a0JR, Bryant\u00a0RL, Petrino\u00a0RA et\u00a0al (1982) Advanced hidradenitis suppurativa. Review of surgical treatment in 23\u00a0patients. Am J Surg 144:668\u2013670","journal-title":"Am J Surg"},{"key":"4864_CR28","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1590\/abd1806-4841.20131637","volume":"88","author":"NC Fernandes","year":"2013","unstructured":"Fernandes\u00a0NC, Franco\u00a0CPA, Lima\u00a0CMO (2013) Hidradenitis suppurativa: retrospective study of 20\u00a0cases. An Bras Dermatol 88:480\u2013481. https:\/\/doi.org\/10.1590\/abd1806-4841.20131637","journal-title":"An Bras Dermatol"},{"issue":"10","key":"4864_CR29","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1097\/DSS.0000000000001916","volume":"45","author":"A Martorell","year":"2019","unstructured":"Martorell\u00a0A, Giovanardi\u00a0G, Gomez-Palencia\u00a0P, Sanz-Motilva\u00a0V (2019) Defining fistular patterns in hidradenitis suppurativa. Dermatol Surg 45(10):1237\u20131244","journal-title":"Dermatol Surg"},{"key":"4864_CR30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.bjps.2015.12.004","volume":"69","author":"LS Humphries","year":"2016","unstructured":"Humphries\u00a0LS, Kueberuwa\u00a0E, Beederman\u00a0M, Gottlieb\u00a0LJ (2016) Wide excision and healing by secondary intent for the surgical treatment of hidradenitis suppurativa: a single-center experience. J\u00a0Plast Reconstr Aesthet Surg 69:554\u2013566. https:\/\/doi.org\/10.1016\/j.bjps.2015.12.004","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"4864_CR31","first-page":"309","volume":"79","author":"RW Parks","year":"1997","unstructured":"Parks\u00a0RW, Parks\u00a0TG, Hughes\u00a0LE (1997) Pathogenesis, clinical features and management of hidradenitis suppurativa. Ann R Coll Surg Engl 79:309\u2013310","journal-title":"Ann R Coll Surg Engl"},{"key":"4864_CR32","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1046\/j.1524-4725.2000.00043.x","volume":"26","author":"R Rompel","year":"2000","unstructured":"Rompel\u00a0R, Petres\u00a0J (2000) Long-term results of wide surgical excision in 106\u00a0patients with hidradenitis suppurativa. Dermatol Surg 26:638\u2013643","journal-title":"Dermatol Surg"},{"key":"4864_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijscr.2015.08.028","volume":"15","author":"H Takiyama","year":"2015","unstructured":"Takiyama\u00a0H, Kazama\u00a0S, Tanoue\u00a0Y et\u00a0al (2015) Efficacy of magnetic resonance imaging in the diagnosis of perianal hidradenitis suppurativa, complicated by anal fistulae: a\u00a0report of two cases and review of the literature. Int J Surg Case Rep 15:107\u2013111. https:\/\/doi.org\/10.1016\/j.ijscr.2015.08.028","journal-title":"Int J Surg Case Rep"},{"key":"4864_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00105-017-4114-1","volume":"69","author":"L Scholl","year":"2018","unstructured":"Scholl\u00a0L, Hessam\u00a0S, Reitenbach\u00a0S, Bechara\u00a0FG (2018) Operative Behandlungsoptionen bei Hidradenitis suppurativa\/Acne inversa. Hautarzt 69:149\u2013161. https:\/\/doi.org\/10.1007\/s00105-017-4114-1","journal-title":"Hautarzt"},{"key":"4864_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/00006534-197607000-00007","volume":"58","author":"S Ariyan","year":"1976","unstructured":"Ariyan\u00a0S, Krizek\u00a0TJ (1976) Hidradenitis suppurativa of the groin, treated by excision and spontaneous healing. Plast Reconstr Surg 58:44\u201347","journal-title":"Plast Reconstr Surg"},{"key":"4864_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1742-481X.2006.00235.x","volume":"3","author":"S Ather","year":"2006","unstructured":"Ather\u00a0S, Chan\u00a0DSY, Leaper\u00a0DJ, Harding\u00a0KG (2006) Surgical treatment of hidradenitis suppurativa: case series and review of the literature. Int Wound\u00a0J 3:159\u2013169. https:\/\/doi.org\/10.1111\/j.1742-481X.2006.00235.x","journal-title":"Int Wound J"},{"key":"4864_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00268-008-9845-9","volume":"33","author":"E Balik","year":"2009","unstructured":"Balik\u00a0E, Eren\u00a0T, Bulut\u00a0T et\u00a0al (2009) Surgical approach to extensive hidradenitis suppurativa in the perineal\/perianal and gluteal regions. World J Surg 33:481\u2013487. https:\/\/doi.org\/10.1007\/s00268-008-9845-9","journal-title":"World J Surg"},{"issue":"4","key":"4864_CR38","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.surg.2005.06.053","volume":"138","author":"RJ Kagan","year":"2019","unstructured":"Kagan\u00a0RJ, Yakuboff\u00a0KP, Warner\u00a0P, Warden\u00a0GD (2019) Surgical treatment of hidradenitis suppurativa: a\u00a010-year experience. Surgery 138(4):734\u2013741","journal-title":"Surgery"},{"key":"4864_CR39","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1111\/j.1524-4725.2010.01763.x","volume":"36","author":"A Bieniek","year":"2010","unstructured":"Bieniek\u00a0A, Matusiak\u00a0L, Okulewicz-Gojlik\u00a0D, Szepietowski\u00a0JC (2010) Surgical treatment of hidradenitis suppurativa: experiences and recommendations. Dermatol Surg 36:1998\u20132004. https:\/\/doi.org\/10.1111\/j.1524-4725.2010.01763.x","journal-title":"Dermatol Surg"},{"key":"4864_CR40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/bmj.294.6570.487","volume":"294","author":"BJ Harrison","year":"1987","unstructured":"Harrison\u00a0BJ, Mudge\u00a0M, Hughes\u00a0LE (1987) Recurrence after surgical treatment of hidradenitis suppurativa. Br Med\u00a0J 294:487\u2013489","journal-title":"Br Med J"},{"key":"4864_CR41","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/01.DCR.0000070046.16402.DF","volume":"46","author":"SF Bocchini","year":"2003","unstructured":"Bocchini\u00a0SF, Habr-Gama\u00a0A, Kiss\u00a0DR et al (2003) Gluteal and perianal hidradenitis suppurativa: surgical treatment by wide excision. Dis Colon Rectum 46:944\u2013949. https:\/\/doi.org\/10.1097\/01.DCR.0000070046.16402.DF","journal-title":"Dis Colon Rectum"},{"key":"4864_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1524-4725.2011.02157.x","volume":"38","author":"U Wollina","year":"2012","unstructured":"Wollina\u00a0U, Tilp\u00a0M, Meseg\u00a0A et\u00a0al (2012) Management of severe anogenital acne inversa (hidradenitis suppurativa). Dermatol Surg 38:110\u2013117. https:\/\/doi.org\/10.1111\/j.1524-4725.2011.02157.x","journal-title":"Dermatol Surg"},{"key":"4864_CR43","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1468-3083.2011.04203.x","volume":"26","author":"DC van Rappard","year":"2012","unstructured":"van Rappard\u00a0DC, Mooij\u00a0JE, Mekkes\u00a0JR (2012) Mild to moderate hidradenitis suppurativa treated with local excision and primary closure. J\u00a0Eur Acad Dermatol Venereol 26:898\u2013902. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04203.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4864_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1524-4725.1982.tb00303.x","volume":"8","author":"A Gr\u00f6sser","year":"1982","unstructured":"Gr\u00f6sser\u00a0A (1982) Surgical treatment of chronic axillary and genitocrural acne conglobata by splitthickness skin grafting. J\u00a0Dermatol Surg Oncol 8:391\u2013398. https:\/\/doi.org\/10.1111\/j.1524-4725.1982.tb00303.x","journal-title":"J Dermatol Surg Oncol"},{"key":"4864_CR45","first-page":"237","volume":"72","author":"EB Mustafa","year":"1980","unstructured":"Mustafa\u00a0EB, Ali\u00a0SD, Kurtz\u00a0LH (1980) Hidradenitis suppurativa: review of the literature and management of the axillary lesion. J\u00a0Natl Med Assoc 72:237\u2013243","journal-title":"J Natl Med Assoc"},{"key":"4864_CR46","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0007-1226(85)90022-0","volume":"38","author":"JD Watson","year":"1985","unstructured":"Watson\u00a0JD (1985) Hidradenitis suppurativa\u2013A clinical review. Br J Plast Surg 38:567\u2013569. https:\/\/doi.org\/10.1016\/0007-1226(85)90022-0","journal-title":"Br J Plast Surg"},{"key":"4864_CR47","first-page":"999","volume":"74","author":"BB Anderson","year":"1982","unstructured":"Anderson\u00a0BB, Cadogan\u00a0CA, Gangadharam\u00a0D (1982) Hidradenitis suppurativa of the perineum, scrotum, and gluteal area: presentation, complications, and treatment. J\u00a0Natl Med Assoc 74:999\u20131003","journal-title":"J Natl Med Assoc"},{"key":"4864_CR48","first-page":"328","volume":"64","author":"J Chapman","year":"1972","unstructured":"Chapman\u00a0J (1972) The surgical treatment of hidradenitis suppurativa. J\u00a0Natl Med Assoc 64:328\u2013330","journal-title":"J Natl Med Assoc"},{"issue":"6","key":"4864_CR49","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/jdv.15353","volume":"33","author":"\u00d8 Grimstad","year":"2019","unstructured":"Grimstad \u00d8, Tzellos\u00a0T, Dufour\u00a0DN, Bremnes \u00d8, Skoie\u00a0IM, Snekvik\u00a0I et al (2019) Evaluation of medical and surgical treatments for hidradenitis suppurativa using real-life data from the Scandinavian registry (HISREG). J\u00a0Eur Acad Dermatol Venereol 33(6):1164\u20131171","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4864_CR50","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1524-4725.2003.29044.x","volume":"29","author":"H Kuo","year":"2003","unstructured":"Kuo\u00a0H, Ohara\u00a0K (2003) Surgical treatment of chronic gluteal hidradenitis suppurativa: reused skin graft technique. Dermatol Surg 29:173\u2013178. https:\/\/doi.org\/10.1046\/j.1524-4725.2003.29044.x","journal-title":"Dermatol Surg"},{"key":"4864_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/BCR.0b013e31826a7be7","volume":"34","author":"TA Gonzaga","year":"2013","unstructured":"Gonzaga\u00a0TA, Endorf\u00a0FW, Mohr\u00a0WJ, Ahrenholz\u00a0DH (2013) Novel surgical approach for axillary hidradenitis suppurativa using a\u00a0bilayer dermal regeneration template: a\u00a0retrospective case study. J\u00a0Burn Care Res 34:51\u201357. https:\/\/doi.org\/10.1097\/BCR.0b013e31826a7be7","journal-title":"J Burn Care Res"},{"key":"4864_CR52","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/dsu.12435","volume":"40","author":"WB Rockwell","year":"2014","unstructured":"Rockwell\u00a0WB, Yamashita\u00a0Y, Hashimoto\u00a0I et al (2014) Commentary: two-stage surgery for hidradenitis suppurativa: staged artificial dermis and skin grafting. Dermatol Surg 40:116\u2013117. https:\/\/doi.org\/10.1111\/dsu.12435","journal-title":"Dermatol Surg"},{"key":"4864_CR53","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1097\/01.PRS.0000157013.40191.91","volume":"115","author":"ET Melkun","year":"2005","unstructured":"Melkun\u00a0ET, Few\u00a0JW (2005) The use of biosynthetic skin substitute (Biobrane) for axillary reconstruction after surgical excision for hidradenitis suppurativa. Plast Reconstr Surg 115:1385\u20131388. https:\/\/doi.org\/10.1097\/01.PRS.0000157013.40191.91","journal-title":"Plast Reconstr Surg"},{"key":"4864_CR54","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/00000637-199706000-00001","volume":"38","author":"MJ Morykwas","year":"1997","unstructured":"Morykwas\u00a0MJ, Argenta\u00a0LC, Shelton-Brown\u00a0EI, McGuirt\u00a0W (1997) Vacuum-assisted closure: a\u00a0new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg 38:553\u2013562","journal-title":"Ann Plast Surg"},{"key":"4864_CR55","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/j.1524-4725.2011.01961.x","volume":"37","author":"O B\u00fcy\u00fcka\u015fik","year":"2011","unstructured":"B\u00fcy\u00fcka\u015fik\u00a0O, Hasdemir\u00a0AO, Kahramansoy\u00a0N et\u00a0al (2011) Surgical approach to extensive hidradenitis suppurativa. Dermatol Surg 37:835\u2013842. https:\/\/doi.org\/10.1111\/j.1524-4725.2011.01961.x","journal-title":"Dermatol Surg"},{"key":"4864_CR56","doi-asserted-by":"publisher","DOI":"10.2478\/s11536-009-0126-2","author":"B Civelek","year":"2010","unstructured":"Civelek\u00a0B, Aksoy\u00a0K, Bilgen\u00a0E et\u00a0al (2010) Reconstructive options in severe cases of Hidradenitis suppurativa. Open Med. https:\/\/doi.org\/10.2478\/s11536-009-0126-2","journal-title":"Open Med"},{"key":"4864_CR57","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.bjps.2004.10.022","volume":"58","author":"N Rehman","year":"2005","unstructured":"Rehman\u00a0N, Kannan\u00a0RY, Hassan\u00a0S, Hart\u00a0NB (2005) Thoracodorsal artery perforator (TAP) type I V\u2011Y advancement flap in axillary hidradenitis suppurativa. Br J Plast Surg 58:441\u2013444. https:\/\/doi.org\/10.1016\/j.bjps.2004.10.022","journal-title":"Br J Plast Surg"},{"key":"4864_CR58","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s001040170004","volume":"72","author":"S Altmann","year":"2001","unstructured":"Altmann\u00a0S, Fansa\u00a0H, Schneider\u00a0W (2001) Surgical treatment of axillary hidradenitis suppurativa. Chirurg 72:1413\u20131416","journal-title":"Chirurg"},{"key":"4864_CR59","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.bjps.2008.04.035","volume":"62","author":"UM Rieger","year":"2009","unstructured":"Rieger\u00a0UM, Erba\u00a0P, Pierer\u00a0G, Kalbermatten\u00a0DF (2009) Hidradenitis suppurativa of the groin treated by radical excision and defect closure by medial thigh lift: aesthetic surgery meets reconstructive surgery. J\u00a0Plast Reconstr Aesthet Surg 62:1355\u20131360. https:\/\/doi.org\/10.1016\/j.bjps.2008.04.035","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"4864_CR60","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1054\/bjps.1999.3285","volume":"53","author":"MG Soldin","year":"2000","unstructured":"Soldin\u00a0MG, Tulley\u00a0P, Kaplan\u00a0H et\u00a0al (2000) Chronic axillary hidradenitis\u2013the efficacy of wide excision and flap coverage. Br J Plast Surg 53:434\u2013436. https:\/\/doi.org\/10.1054\/bjps.1999.3285","journal-title":"Br J Plast Surg"},{"key":"4864_CR61","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.det.2015.08.007","volume":"34","author":"I Janse","year":"2016","unstructured":"Janse\u00a0I, Bieniek\u00a0A, Horv\u00e1th\u00a0B, Matusiak\u00a0L (2016) Surgical procedures in hidradenitis suppurativa. Dermatol Clin 34:97\u2013109. https:\/\/doi.org\/10.1016\/j.det.2015.08.007","journal-title":"Dermatol Clin"},{"key":"4864_CR62","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/BF02052316","volume":"33","author":"O Wiltz","year":"1990","unstructured":"Wiltz\u00a0O, Schoetz\u00a0DJ, Murray\u00a0JJ et\u00a0al (1990) Perianal hidradenitis suppurativa. The Lahey clinic experience. Dis Colon Rectum 33:731\u2013734","journal-title":"Dis Colon Rectum"},{"key":"4864_CR63","first-page":"235","volume":"65","author":"WP Morgan","year":"1983","unstructured":"Morgan\u00a0WP, Harding\u00a0KG, Hughes\u00a0LE (1983) A comparison of skin grafting and healing by granulation, following axillary excision for hidradenitis suppurativa. Ann R Coll Surg Engl 65:235\u2013236","journal-title":"Ann R Coll Surg Engl"},{"key":"4864_CR64","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/ijd.13393","volume":"56","author":"U Wollina","year":"2017","unstructured":"Wollina\u00a0U, Langner\u00a0D, Heinig\u00a0B, Nowak\u00a0A (2017) Comorbidities, treatment, and outcome in severe anogenital inverse acne (hidradenitis suppurativa): a\u00a015-year single center report. Int J Dermatol 56:109\u2013115. https:\/\/doi.org\/10.1111\/ijd.13393","journal-title":"Int J Dermatol"},{"key":"4864_CR65","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.surg.2005.06.053","volume":"138","author":"RJ Kagan","year":"2005","unstructured":"Kagan\u00a0RJ, Yakuboff\u00a0KP, Warner\u00a0P, Warden\u00a0GD (2005) Surgical treatment of hidradenitis suppurativa: a\u00a010-year experience. Surgery 138:734\u2013740. https:\/\/doi.org\/10.1016\/j.surg.2005.06.053 ((discussion 740\u2013741))","journal-title":"Surgery"},{"issue":"5","key":"4864_CR66","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/jdv.15332","volume":"33","author":"V Bettoli","year":"2019","unstructured":"Bettoli\u00a0V, Manfredini\u00a0M, Massoli\u00a0L, Carillo\u00a0C, Barozzi\u00a0A, Amendolagine\u00a0G et\u00a0al (2019) Rates of antibiotic resistance\/sensitivity in bacterial cultures of hidradenitis suppurativa patients. J\u00a0Eur Acad Dermatol Venereol 33(5):930\u2013936","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"4864_CR67","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jaad.2018.12.043","volume":"80","author":"L Schneller-Pavelescu","year":"2019","unstructured":"Schneller-Pavelescu\u00a0L, Vergara-de Caso\u00a0E, Martorell\u00a0A, Roman\u00ed\u00a0J, L\u00e1zaro\u00a0M, Vilarrasa\u00a0E et al (2019) Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: an observational study to assess prevalence and causes. J\u00a0Am Acad Dermatol 80(5):1455\u20131457","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"4864_CR68","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/bjd.17265","volume":"180","author":"J Albrecht","year":"2019","unstructured":"Albrecht\u00a0J, Baine\u00a0PA, Ladizinski\u00a0B, Jemec\u00a0GB, Bigby\u00a0M (2019) Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a\u00a0critically appraised topic. Br J Dermatol 180(4):749\u2013755","journal-title":"Br J Dermatol"},{"issue":"4","key":"4864_CR69","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/bjd.17423","volume":"180","author":"C Marasca","year":"2019","unstructured":"Marasca\u00a0C, Masar\u00e0\u00a0A, Annunziata\u00a0MC, Bettoli\u00a0V, Luciano\u00a0MA, Fabbrocini\u00a0G (2019) Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: strategy to reduce side effects, improving patients\u2019 compliance. Br J Dermatol 180(4):949","journal-title":"Br J Dermatol"},{"key":"4864_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.01.007","author":"M Delage","year":"2020","unstructured":"Delage M, Jais JP, Lam T, Guet-Revillet H, Ungeheuer MN, Consigny PH et al (2020) Rifampin-moxifloxacin-metronidazole combination therapy for severe Hurley stage 1 hidradenitis suppurativa: prospective short-term trial and one-year follow-up in 28\u00a0consecutive patients. J\u00a0Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2020.01.007","journal-title":"Am Acad Dermatol"},{"key":"4864_CR71","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.clindermatol.2016.10.018","volume":"35","author":"RK Andersen","year":"2017","unstructured":"Andersen\u00a0RK, Jemec\u00a0GB (2017) Treatments for hidradenitis suppurativa. Clin Dermatol 35:218\u2013224. https:\/\/doi.org\/10.1016\/j.clindermatol.2016.10.018","journal-title":"Clin Dermatol"},{"key":"4864_CR72","doi-asserted-by":"publisher","first-page":"219S","DOI":"10.1097\/PRS.0000000000002671","volume":"138","author":"RA Falola","year":"2016","unstructured":"Falola\u00a0RA, DeFazio\u00a0MV, Anghel\u00a0EL et\u00a0al (2016) What heals hidradenitis suppurativa: surgery, immunosuppression, or both? Plast Reconstr Surg 138:219S\u2013229S. https:\/\/doi.org\/10.1097\/PRS.0000000000002671","journal-title":"Plast Reconstr Surg"},{"key":"4864_CR73","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1365-2133.2012.10807.x","volume":"167","author":"DC Van Rappard","year":"2012","unstructured":"Van Rappard\u00a0DC, Mekkes\u00a0JR (2012) Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions. Br J Dermatol 167:206\u2013208. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10807.x","journal-title":"Br J Dermatol"},{"issue":"1","key":"4864_CR74","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","volume":"81","author":"A Alikhan","year":"2019","unstructured":"Alikhan\u00a0A, Sayed\u00a0C, Alavi\u00a0A, Alhusayen\u00a0R, Brassard\u00a0A, Burkhart\u00a0C et\u00a0al (2019) North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J\u00a0Am Acad Dermatol 81(1):91\u2013101","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"4864_CR75","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/bjd.17151","volume":"180","author":"M Argyropoulou","year":"2019","unstructured":"Argyropoulou\u00a0M, Kanni\u00a0T, Kyprianou\u00a0M, Melachroinopoulos\u00a0N, Giamarellos-Bourboulis\u00a0EJ (2019) Cost-savings of adalimumab in hidradenitis suppurativa: a\u00a0retrospective analysis of a\u00a0real-world cohort. Br J Dermatol 180(5):1161\u20131168","journal-title":"Br J Dermatol"},{"issue":"1","key":"4864_CR76","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaad.2018.05.040","volume":"80","author":"CC Zouboulis","year":"2019","unstructured":"Zouboulis\u00a0CC, Okun\u00a0MM, Prens\u00a0EP, Gniadecki\u00a0R, Foley\u00a0PA, Lynde\u00a0C et al (2019) Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa\/acne inversa: 3\u2011year results of a\u00a0phase 3 open-label extension study. J\u00a0Am Acad Dermatol 80(1):60\u201369.e2","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"4864_CR77","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/bjd.17919","volume":"181","author":"GB Jemec","year":"2019","unstructured":"Jemec\u00a0GB, Okun\u00a0MM, Forman\u00a0SB, Gulliver\u00a0WP, Prens\u00a0EP, Mrowietz\u00a0U et al (2019) Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase 3, randomized, placebo-controlled, PIONEER trials. Br J Dermatol 181(5):967\u2013975","journal-title":"Br J Dermatol"},{"issue":"3","key":"4864_CR78","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jaad.2019.05.022","volume":"81","author":"AN Oskardmay","year":"2019","unstructured":"Oskardmay\u00a0AN, Miles\u00a0JA, Sayed\u00a0CJ (2019) Determining the optimal dose of infliximab for treatment of hidradenitis suppurativa. J\u00a0Am Acad Dermatol 81(3):702\u2013708","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4864_CR79","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jaad.2018.06.046","volume":"80","author":"AR Vossen","year":"2019","unstructured":"Vossen\u00a0AR, van Doorn\u00a0MB, van der Zee\u00a0HH, Prens\u00a0EP (2019) Apremilast for moderate hidradenitis suppurativa: results of a\u00a0randomized controlled trial. J\u00a0Am Acad Dermatol 80(1):80\u201388","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"4864_CR80","first-page":"170","volume":"18","author":"FR Kerdel","year":"2019","unstructured":"Kerdel\u00a0FR, Azevedo\u00a0FA, Kerdel\u00a0Don C, Don\u00a0FA, Fabbrocini\u00a0G, Kerdel\u00a0FA (2019) Apremilast for the treatment of mild-to-moderate hidradenitis suppurativa in a\u00a0prospective, open-label, phase 2 study. J\u00a0Drugs Dermatol 18(2):170\u2013176","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"4864_CR81","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1111\/ijd.14596","volume":"58","author":"R Andr\u00e9","year":"2019","unstructured":"Andr\u00e9\u00a0R, Marescassier\u00a0H, Gabay\u00a0C, Pittet\u00a0B, Laffitte\u00a0E (2019) Long-term therapy with anakinra in hidradenitis suppurativa in three patients. Int J Dermatol 58(11):e208\u2013e209","journal-title":"Int J Dermatol"},{"issue":"3","key":"4864_CR82","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/bjd.17822","volume":"181","author":"L Prussick","year":"2019","unstructured":"Prussick\u00a0L, Rothstein\u00a0B, Joshipura\u00a0D, Saraiya\u00a0A, Turkowski\u00a0Y, Abdat\u00a0R et al (2019) Open-label, investigator-initiated, singlesite exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa. Br J Dermatol 181(3):609\u2013611","journal-title":"Br J Dermatol"},{"issue":"1","key":"4864_CR83","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jaad.2018.12.017","volume":"81","author":"RG Casseres","year":"2019","unstructured":"Casseres\u00a0RG, Kahn\u00a0JS, Her\u00a0MJ, Rosmarin\u00a0D (2019) Guselkumab in the treatment of hidradenitis suppurativa: a\u00a0retrospective chart review. J\u00a0Am Acad Dermatol 81(1):265\u2013267","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"4864_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5070\/D35VW402NF","volume":"19","author":"N Scheinfeld","year":"2013","unstructured":"Scheinfeld\u00a0N (2013) Hidradenitis suppurativa: a practical review of possible medical treatments based on over 350 hidradenitis patients. Dermatol Online\u00a0J 19(4):1","journal-title":"Dermatol Online J"},{"issue":"3","key":"4864_CR85","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/pde.13775","volume":"36","author":"LE Provini","year":"2019","unstructured":"Provini\u00a0LE, Stellar\u00a0JJ, Stetzer\u00a0MN, Nguyen\u00a0PD, Jen\u00a0M (2019) Combination hyperbaric oxygen therapy and ustekinumab for severe hidradenitis suppurativa. Pediatr Dermatol 36(3):381\u2013383","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"4864_CR86","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1111\/jdv.15368","volume":"33","author":"M Kovacs","year":"2019","unstructured":"Kovacs\u00a0M, Podda\u00a0M (2019) Guselkumab in the treatment of severe hidradenitis suppurativa. J\u00a0Eur Acad Dermatol Venereol 33(3):e140\u2013e141","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4864_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.02.005","author":"RG Casseres","year":"2020","unstructured":"Casseres\u00a0RG, Prussick\u00a0L, Zacanaro\u00a0R, Rothstein\u00a0B, Joshipura\u00a0D et\u00a0al (2020) Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: results of an open label trial. J\u00a0Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2020.02.005","journal-title":"J Am Acad Dermatol"},{"key":"4864_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2020.02.007","author":"KT Savage","year":"2020","unstructured":"Savage\u00a0KT, Brant\u00a0EG, Santillan\u00a0MR, Morss\u00a0PC, Salian\u00a0P et\u00a0al (2020) Methotrexate shows benefit in a\u00a0subset of patients with severe hidradenitis suppurativa. Int J Womens Dermatol. https:\/\/doi.org\/10.1016\/j.ijwd.2020.02.007","journal-title":"Int J Womens Dermatol"},{"key":"4864_CR89","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/exd.14339","volume":"30","author":"EJ Giamarellos-Bourboulis","year":"2021","unstructured":"Giamarellos-Bourboulis\u00a0EJ, Bettoli\u00a0V, Jemec\u00a0GBE, del Marmol\u00a0V, Marzano\u00a0AV, Prens\u00a0EP, Tzellos\u00a0T, Zouboulis\u00a0CC (2021) Anti-COVID-19 measurements for hidradenitis suppurativa patients. Exp Dermatol 30:18\u201322","journal-title":"Exp Dermatol"},{"key":"4864_CR90","first-page":"82","volume":"30","author":"M Kovacs","year":"2021","unstructured":"Kovacs\u00a0M, Podda\u00a0M (2021) Current changes in the standard of care of hidradenitis suppurativa patients in a\u00a0German specialist clinic due to the COVID-19 pandemic. Exp Dermatol 30:82","journal-title":"Exp Dermatol"},{"key":"4864_CR91","first-page":"70","volume":"30","author":"M Podda","year":"2021","unstructured":"Podda\u00a0M, Hasche\u00a0E, Kovacs\u00a0M (2021) Tumescence vs. general anesthesia: a\u00a0precious alternative in large hidradenitis suppurativa surgery learned due to the COVID-19 pandemic. Exp Dermatol 30:70\u201371","journal-title":"Exp Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04864-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04864-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04864-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T08:03:39Z","timestamp":1627545819000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04864-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":91,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4864"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04864-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]},"assertion":[{"value":"23 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Cramer hat von der Firma Novartis und Incyte gesponserte Phase-II- und -III-Studien betreut. S.\u00a0Schneider-Burrus erhielt Reisekostenunterst\u00fctzung oder Verg\u00fctung f\u00fcr T\u00e4tigkeiten im Rahmen klinischer Studien, Referenten- oder Beratert\u00e4tigkeiten in alphabetischer Reihenfolge von folgenden Firmen: AbbVie Inc., AbbVie Deutschland GmbH & Co. KG, Biogen GmbH Deutschland, Novartis Pharma GmbH, Roche Germany GmbH, UCB Pharma GmbH, Deutschland. L.\u00a0Scholl hat von der Firma Novartis und Incyte gesponserte Phase-II- und -III-Studien betreut. F.\u00a0G.\u00a0Bechara: Referentent\u00e4tigkeit und Advisory Boards: AbbVie, Novartis, Janssen. Durchf\u00fchrung klinischer Studien: AbbVie, Novartis, Janssen, UCB, Incyte, Inflarx. M.\u00a0Podda hat als Redner oder Berater von AbbVie, CSL, Boehringer Ingelheim, Eli Lilly, Janssen-Cilag, InflaRx, Novartis und UCB Honorare erhalten oder an klinischen Studien teilgenommen. M.\u00a0Kov\u00e1cs hat als Redner oder Berater von AbbVie, Janssen-Cilag, UCB und Leo Pharma Honorare erhalten oder an klinischen Studien teilgenommen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}